Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

Phase 2

Completed

• Conditions: Muscle Tear
• Interventions: Biological: PRGF; Biological: Placebo

• Registration Number: NCT00726245
• Lead Sponsor: Meir Medical Center

Brief Summary

the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Study First Submitted: 2008-07-29
• Study First Submitted QC: 2008-07-30
• Study First Posted: 2008-07-31
• Primary Completion: 2009-02
• Study Completion: 2011-03
• Status Verified: 2011-07
• Last Update Submitted: 2011-07-10
• Last Update Posted: 2011-07-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• US diagnosed muscle tear
• age 15-40 years old

Exclusion Criteria

• pregnancy
• mental or physical disabilities

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	PRGF	PRGF
2	Placebo	physiological saline

Primary Outcome Measures

Name	Time	Method
improvement of symptoms / disease progress	1 year

Trial Locations

Locations (1)

Meir Medicak Center; 🇮🇱 Kfar Saba, Israel